Cargando…

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model

Detalles Bibliográficos
Autor principal:	Silvestrini, Rosella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2005
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617495/ https://www.ncbi.nlm.nih.gov/pubmed/16373968 http://dx.doi.org/10.1155/2005/832494

Ejemplares similares

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Baak, Jan P. A., et al.
Publicado: (2005)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Kruse, Arnold-Jan, et al.
Publicado: (2004)

Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1–2 lesions
por: Li, Yuejie, et al.
Publicado: (2019)

Comment on: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium
por: dos Santos Martins, Thiago Gonçalves
Publicado: (2021)

Quantitative Histopathological Analysis of CIN Sections
por: Baak, Jan P. A.
Publicado: (2006)

Quantitative Histopathological Analysis of CIN Sections
por: Guillaud, Martial, et al.
Publicado: (2006)

Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
por: Bruno, Maria Teresa, et al.
Publicado: (2021)

Clinical validity and clinical utility of Ki67 in early breast cancer
por: Kreipe, Hans, et al.
Publicado: (2022)

The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL
por: Possati-Resende, Júlio C., et al.
Publicado: (2015)

Three-tiered score for Ki-67 and p16(ink4a) improves accuracy and reproducibility of grading CIN lesions
por: van Zummeren, Marjolein, et al.
Publicado: (2018)

Predictive Role of Telomerase Activity in the Clinical Outcome of Patients with Benign Lesions of the Uterine Cervix or CIN
por: Bravaccini, Sara, et al.
Publicado: (2012)

Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision-Making: A New Way of Counting
por: Bulloni, Matteo, et al.
Publicado: (2021)

Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6, Ki-67, and telomerase
por: Vega-Peña, Arianna, et al.
Publicado: (2013)

P16INK4a/ki67 Immunocytochemistry in Improving the Predictive Value for High Grade Cervical Intraepithelial (≥CIN2) Neoplasia in Pap Smear
por: Kumar, G Vinoth, et al.
Publicado: (2021)

Prognostic Value of Ki67 in Patients with Stage 1–2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor
por: Jiang, Peng, et al.
Publicado: (2020)

In Response to “Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting”
por: Belderbos, Robert A., et al.
Publicado: (2021)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Is Ki-67 a prognostic factor for post-operation survival in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma?
por: Li, Changcan, et al.
Publicado: (2022)

Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer
por: Wishart, Gordon C, et al.
Publicado: (2014)

Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial
por: Major, Attila Louis, et al.
Publicado: (2020)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Developing a multivariable risk prediction model to predict prolonged viral clearance in patients with COVID-19
por: Liu, Ying, et al.
Publicado: (2021)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms
por: Panzuto, Francesco, et al.
Publicado: (2017)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The progress in our understanding of CIN in breast cancer research
por: Liao, Yu-Yang, et al.
Publicado: (2023)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Meiotic-Like Division to a Aneuploidy: Chromosomal Instability (CIN), Cell-Senescence and Cancer
por: Walen, Kirsten H.
Publicado: (2008)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Predict the Progression of Cervical Intraepithelial Neoplasia by a Novel Marker Folate Combine with FRα, p16 and Ki-67
por: Liu, Tingting, et al.
Publicado: (2022)

The Potential Value of Ki-67 in Prognostic Classification in Early Low-Risk Endometrial Cancer
por: Jia, Mingzhu, et al.
Publicado: (2023)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Proliferative Index (Ki67) for Prediction in Breast Duct Carcinomas
por: Ahmed, Shatha Th, et al.
Publicado: (2018)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

Uterine leiomyosarcoma in a wild rat (Rattus norvegicus): usefulness of Ki-67 labeling index for diagnosis
por: Jeon, Byung-Suk, et al.
Publicado: (2013)

Development and validation of combined Ki67 status prediction model for intrahepatic cholangiocarcinoma based on clinicoradiological features and MRI radiomics
por: Qian, Xianling, et al.
Publicado: (2023)

Risk of confounding variables in multivariate analysis
por: Gagnon, Bruno, et al.
Publicado: (2022)

Predictive value of p53, Ki67 and TLR5 in neoplastic progression of Barrett’s esophagus: a matched case–control study
por: Helminen, Olli, et al.
Publicado: (2022)

The Role of p16/Ki-67 Immunostaining, hTERC Amplification and Fibronectin in Predicting Cervical Cancer Progression: A Systematic Review
por: Voidăzan, Septimiu Toader, et al.
Publicado: (2022)

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
por: Magnusson, Kristina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1mpc07ce8k8lc6k2h5sc0sdv4n